Avalon Investment & Advisory’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-4,880
Closed -$460K 360
2019
Q1
$460K Buy
4,880
+1,702
+54% +$149K 0.01% 276
2018
Q4
$204K Sell
3,178
-148,863
-98% -$11M 0.01% 299
2018
Q3
$13.6M Buy
152,041
+149,213
+5,276% +$13.2M 0.38% 93
2018
Q2
$225K Sell
2,828
-210
-7% -$17.4K 0.01% 332
2018
Q1
$271K Sell
3,038
-87,245
-97% -$8.38M 0.01% 324
2017
Q4
$9.42M Sell
90,283
-2,568
-3% -$290K 0.29% 123
2017
Q3
$13.5M Sell
92,851
-2,262
-2% -$308K 0.43% 88
2017
Q2
$12.4M Buy
95,113
+34,658
+57% +$4.25M 0.41% 95
2017
Q1
$7.52M Sell
60,455
-47,540
-44% -$5.69M 0.26% 121
2016
Q4
$12.5M Buy
107,995
+4,750
+5% +$529K 0.45% 76
2016
Q3
$10.8M Buy
103,245
+47,485
+85% +$5.14M 0.41% 86
2016
Q2
$5.5M Sell
55,760
-86,425
-61% -$8.94M 0.21% 102
2016
Q1
$14.2M Sell
142,185
-1,132
-0.8% -$117K 0.62% 63
2015
Q4
$17.2M Sell
143,317
-12,432
-8% -$1.44M 0.74% 52
2015
Q3
$16.8M Buy
155,749
+8,540
+6% +$1.06M 0.74% 49
2015
Q2
$17M Buy
147,209
+3,126
+2% +$357K 0.73% 53
2015
Q1
$16.6M Buy
144,083
+5,976
+4% +$714K 0.73% 57
2014
Q4
$15.4M Buy
138,107
+12,614
+10% +$1.33M 0.7% 54
2014
Q3
$11.9M Buy
125,493
+2,659
+2% +$240K 0.6% 62
2014
Q2
$10.5M Buy
122,834
+3,950
+3% +$300K 0.53% 75
2014
Q1
$8.3M Sell
118,884
-3,432
-3% -$272K 0.46% 96
2013
Q4
$10.3M Buy
122,316
+1,128
+0.9% +$89.3K 0.58% 68
2013
Q3
$9.34M Sell
121,188
-57,704
-32% -$4.04M 0.6% 65
2013
Q2
$10.5M Buy
+178,892
New +$10.8M 0.62% 54

Other funds holding CELG

Avalon Investment & Advisory's CELG Position: Q2 2019 in Review

Avalon Investment & Advisory sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 4,880 shares — an estimated $460K sold.

Avalon Investment & Advisory first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $17.2M in Q4 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Avalon Investment & Advisory reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Avalon Investment & Advisory sold 4,880 Celgene Corp shares in Q2 2019, an estimated $460K.
  • Avalon Investment & Advisory first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Avalon Investment & Advisory's Celgene Corp position peaked at $17.2M in Q4 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Avalon Investment & Advisory's 13F filing for Q2 2019, filed 14 Aug 2019.